Page last updated: 2024-08-24

3-iodobenzylguanidine and Carcinoma, Neuroendocrine

3-iodobenzylguanidine has been researched along with Carcinoma, Neuroendocrine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Jimenez, C; Núñez, R; Wendt, R1
Breza, J1
Bombardieri, E; Chiti, A; Lorenzoni, A; Pepe, G1
Binse, I; Bockisch, A; Brandau, W; Jentzen, W; Poeppel, TD; Richter, M; Schmitz, J1
Divgi, C; Ilias, I; Pacak, K1
Bucerius, J; Mottaghy, FM; Vöö, S1
Bomanji, JB; Papathanasiou, ND1
Bennet, A; Caron, P; Grunenwald, S; Maiza, JC; Otal, P; Vezzosi, D1
Borson-Chazot, F; Giammarile, F1
Cichocki, A; Cwikla, JB; Durlik, M; Jeziorski, KG; Malkowski, B; Nasierowska-Guttmejer, A; Seklecka, N; Stepień, K; Walecki, J; Zgliczynski, W1

Reviews

6 review(s) available for 3-iodobenzylguanidine and Carcinoma, Neuroendocrine

ArticleYear
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
    Current opinion in endocrinology, diabetes, and obesity, 2020, Volume: 27, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Humans; Intestinal Neoplasms; Iodine Radioisotopes; Neoplasm Metastasis; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Rare Diseases; Stomach Neoplasms; Therapies, Investigational; Thyroid Neoplasms

2020
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
    PET clinics, 2014, Volume: 9, Issue:1

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Contraindications; Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Stomach Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon

2014
Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.
    Seminars in nuclear medicine, 2011, Volume: 41, Issue:5

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Biological Transport; Carcinoma, Neuroendocrine; Humans; Pheochromocytoma; Thyroid Neoplasms

2011
I-131-MIBG therapies.
    Methods (San Diego, Calif.), 2011, Volume: 55, Issue:3

    Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Neuroendocrine; Clinical Trials as Topic; Humans; Iodine Radioisotopes

2011
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39 Suppl 1

    Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pentetic Acid; Pheochromocytoma; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms

2012
[Neuroendocrine tumours treated with mIBG and radiolabeled peptides].
    Pathologie-biologie, 2006, Volume: 54, Issue:3

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Neuroendocrine; Combined Modality Therapy; Humans; Neuroblastoma; Paraganglioma; Peptides; Prognosis; Radiopharmaceuticals

2006

Other Studies

4 other study(ies) available for 3-iodobenzylguanidine and Carcinoma, Neuroendocrine

ArticleYear
Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Bratislavske lekarske listy, 2018, Volume: 119, Issue:2

    Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Neuroendocrine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Pedigree; Pheochromocytoma; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult

2018
Discrepant salivary gland response after radioiodine and MIBG therapies.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2017, Volume: 61, Issue:3

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Neuroendocrine; Child; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Dosage; Retrospective Studies; Salivary Glands; Young Adult

2017
Use of 131 I-MIBG therapy in MIBG-positive metastatic medullary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:6

    Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Neuroendocrine; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2012
Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
    Neuro endocrinology letters, 2007, Volume: 28, Issue:6

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Diagnostic Imaging; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2007